Healx Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 74
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $69.5M
Latest Deal Amount
  • Investors
  • 18

Healx General Information

Description

Operator of an AI-powered, patient-inspired tech company, intended to accelerate the discovery and development of treatments for rare diseases. The company's platform uses artificial intelligence to leverage the combination of algorithms to predict and de-risk novel connections in biomedical data and move the promising ones towards the clinic, enabling clinics to develop advanced treatment methods.

Contact Information

Website
www.healx.io
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Technology Systems
Primary Office
  • Charter House
  • 66-68 Hills Road
  • Cambridge CB2 1LA
  • England, United Kingdom

Healx Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Healx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC (Series B) 16-Oct-2019 $69.5M 000.00 00000 Completed Generating Revenue
5. Early Stage VC (Series A) 26-Jul-2018 00.00 000.00 000.00 Completed Generating Revenue
4. Early Stage VC (Series A) 05-Oct-2016 00.000 00.00 000.00 Completed Startup
3. Seed Round 15-Apr-2015 00000 00000 00.000 Completed Startup
2. Grant Completed Startup
1. Accelerator/Incubator 01-Jan-2015 Completed Startup
To view Healx’s complete valuation and funding history, request access »

Healx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.00
Series B 0,000,000 00.000000 00.0 00.0 00 00.0 0.000
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A Pref 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 2,878,000 $0.000000 $0.65 $0.65 1x $0.65 9.17%
Ordinary 2,484,000 $0.000000 $0.15 $0.15 1x $0.15 7.92%
To view Healx’s complete cap table history, request access »

Healx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of an AI-powered, patient-inspired tech company, intended to accelerate the discovery and development of treatm
Drug Discovery
Cambridge, United Kingdom
74 As of 2021
000.00
0000 0000-00-00
00000000000 000.00

00000 00

la pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt moll
0000 000000000
San Francisco, CA
00 As of 0000
000.00
00000000000 000.00

00000000

dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur si
0000 000000000
Oxford, United Kingdom
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Healx Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Verge Genomics Venture Capital-Backed San Francisco, CA 00 000.00 00000000000 000.00
0000000000 Venture Capital-Backed Oxford, United Kingdom 000 00000 00000000000 00000
00000 Venture Capital-Backed Paris, France 00 000.00 00000000000 000.00
00000000 00000000 Venture Capital-Backed Pak Shek Kok, Hong Kong 00 000.00 0000000000 0 000.00
00000 000 Venture Capital-Backed South San Francisco, CA 00 00000 00000000000 00000
You’re viewing 5 of 17 competitors. Get the full list »

Healx Executive Team (24)

Name Title Board Seat Contact Info
Tim Guilliams Ph.D Co-Founder, Chief Executive Officer and Board Member
Meri Williams Chief Technology Officer
Neil Thompson Ph.D Chief Scientific Officer
David Campbell Director, Finance
Charlotte Chorley Director of Strategic Alignment and Communications
You’re viewing 5 of 24 executive team members. Get the full list »

Healx Board Members (9)

Name Representing Role Since
Chiara Sommer Self Board Observer 000 0000
David Brown Ph.D Healx Co-Founder & Chairman 000 0000
Irina Haivas MD Atomico Board Member 000 0000
Jonathan Milner Self Board Member 000 0000
Jonathan Milner Ph.D Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Healx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Healx Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Atomico Venture Capital Minority 000 0000 000000 0
b-to-v Partners Venture Capital Minority 000 0000 000000 0
Daniel Gutenberg Angel (individual) Minority 000 0000 000000 0
Delta2020 Venture Capital Minority 000 0000 000000 0
Global Brain Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 18 investors. Get the full list »

Healx Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 19-Aug-2017 000000000000000000 Business/Productivity Software
To view Healx’s complete acquisitions history, request access »